Birth outcomes of Influenza virus vaccince (Afluria) in Pregnant Women in Lao

Trial Profile

Birth outcomes of Influenza virus vaccince (Afluria) in Pregnant Women in Lao

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 May 2016

At a glance

  • Drugs Influenza virus vaccine (Afluria) (Primary)
  • Indications Influenza virus infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 May 2016 New trial record
    • 03 May 2016 Primary endpoint (Proportion of infants born small for gestational age (SGA)) has not been met, according to the results published in the Clinical Infectious Diseases
    • 03 May 2016 Primary endpoint (The mean birth weight) has not been met, according to the results published in the Clinical Infectious Diseases
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top